{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:14:40Z","timestamp":1791180880548,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T00:00:00Z","timestamp":1271721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/sj.bjc.6605669","type":"journal-article","created":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T20:03:12Z","timestamp":1271793792000},"page":"1483-1490","source":"Crossref","is-referenced-by-count":24,"title":["Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells"],"prefix":"10.1038","volume":"102","author":[{"given":"Y","family":"Tomimaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Marubashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Umeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,20]]},"reference":[{"key":"BF6605669_CR1","first-page":"1862","volume":"46","author":"T Asahara","year":"1999","unstructured":"Asahara T, Itamoto T, Katayama K, Nakahara H, Hino H, Yano M, Ono E, Dohi K, Nakanishi T, Kitamoto M, Azuma K, Itoh K, Shimamoto F (1999) Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures. Hepatogastroenterology 46: 1862\u20131869","journal-title":"Hepatogastroenterology"},{"key":"BF6605669_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/sj.onc.1201772","volume":"16","author":"AM Burger","year":"1998","unstructured":"Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, Papas T, Seth A (1998) Down-regulation of T1A12\/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 16: 2459\u20132467","journal-title":"Oncogene"},{"key":"BF6605669_CR3","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I","volume":"88","author":"YH Chung","year":"2000","unstructured":"Chung YH, Song IH, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ (2000) Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88: 1986\u20131991","journal-title":"Cancer"},{"issue":"Suppl 2","key":"BF6605669_CR4","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1111\/j.1872-034X.2007.00191.x","volume":"37","author":"B Damdinsuren","year":"2007","unstructured":"Damdinsuren B, Nagano H, Monden M (2007a) Combined intra-arterial 5-fluorouracil and subcutaneous interferon-\u03b1 therapy for highly advanced hepatocellular carcinoma. Hepatol Res 37 (Suppl 2): S238\u2013S250","journal-title":"Hepatol Res"},{"key":"BF6605669_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1872-034X.2007.00007.x","volume":"37","author":"B Damdinsuren","year":"2007","unstructured":"Damdinsuren B, Nagano H, Wada H, Noda T, Natsag J, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Monden M (2007b) Interferon \u03b1 receptors are important for antiproliferative effect of interferon-\u03b1 against human hepatocellular carcinoma cells. Hepatol Res 37: 77\u201383","journal-title":"Hepatol Res"},{"key":"BF6605669_CR6","first-page":"2881","volume":"6","author":"H Eguchi","year":"2000","unstructured":"Eguchi H, Nagano H, Yamamoto H, Miyamoto A, Kondo M, Dono K, Nakamori S, Umeshita K, Sakon M, Monden M (2000) Augmentation of antitumor activity of 5-fluorouracil by interferon \u03b1 is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells. Clin Cancer Res 6: 2881\u20132890","journal-title":"Clin Cancer Res"},{"key":"BF6605669_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1148\/radiology.204.3.9280260","volume":"204","author":"J Furuse","year":"1997","unstructured":"Furuse J, Iwasaki M, Yoshino M, Konishi M, Kawano N, Kinoshita T, Ryu M, Satake M, Moriyama N (1997) Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 204: 787\u2013790","journal-title":"Radiology"},{"key":"BF6605669_CR8","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1101\/gad.1371305","volume":"19","author":"SE Hartman","year":"2005","unstructured":"Hartman SE, Bertone P, Nath AK, Royce TE, Gerstein M, Weissman S, Snyder M (2005) Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 19: 2953\u20132968","journal-title":"Genes Dev"},{"key":"BF6605669_CR9","first-page":"83","volume":"17","author":"M Kondo","year":"2000","unstructured":"Kondo M, Nagano H, Sakon M, Yamamoto H, Morimoto O, Arai I, Miyamoto A, Eguchi H, Dono K, Nakamori S, Umeshita K, Wakasa K, Ohmoto Y, Monden M (2000) Expression of interferon \u03b1\/\u03b2 receptor in human hepatocellular carcinoma. Int J Oncol 17: 83\u201388","journal-title":"Int J Oncol"},{"key":"BF6605669_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-05-0274","volume":"11","author":"M Kondo","year":"2005","unstructured":"Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M (2005) Combination of IFN-\u03b1 and 5-fluorouracil induces apoptosis through IFN-\u03b1\/\u03b2 receptor in human hepatocellular carcinoma cells. Clin Cancer Res 11: 1277\u20131286","journal-title":"Clin Cancer Res"},{"key":"BF6605669_CR11","first-page":"4005","volume":"5","author":"M Kondo","year":"1999","unstructured":"Kondo M, Yamamoto H, Nagano H, Okami J, Ito Y, Shimizu J, Eguchi H, Miyamoto A, Dono K, Umeshita K, Matsuura N, Wakasa K, Nakamori S, Sakon M, Monden M (1999) Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin Cancer Res 5: 4005\u20134012","journal-title":"Clin Cancer Res"},{"key":"BF6605669_CR12","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1038\/sj.onc.1204471","volume":"20","author":"G Landberg","year":"2001","unstructured":"Landberg G, Ostlund H, Nielsen NH, Roos G, Emdin S, Burger AM, Seth A (2001) Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene 20: 3497\u20133505","journal-title":"Oncogene"},{"key":"BF6605669_CR13","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2087::AID-CNCR5>3.0.CO;2-M","volume":"79","author":"HS Lee","year":"1997","unstructured":"Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79: 2087\u20132094","journal-title":"Cancer"},{"key":"BF6605669_CR14","first-page":"1676","volume":"5","author":"TW Leung","year":"1999","unstructured":"Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ (1999) Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 5: 1676\u20131681","journal-title":"Clin Cancer Res"},{"key":"BF6605669_CR15","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.4161\/cbt.7.12.6937","volume":"7","author":"J Lin","year":"2008","unstructured":"Lin J, Lai M, Huang Q, Ruan W, Ma Y, Cui J (2008) Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro. Cancer Biol Ther 7: 1896\u20131900","journal-title":"Cancer Biol Ther"},{"key":"BF6605669_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cyto.a.20188","volume":"68","author":"E Lugli","year":"2005","unstructured":"Lugli E, Troiano L, Ferraresi R, Roat E, Prada N, Nasi M, Pinti M, Cooper EL, Cossarizza A (2005) Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A 68: 28\u201335","journal-title":"Cytometry A"},{"key":"BF6605669_CR17","first-page":"7717","volume":"63","author":"K Mutaguchi","year":"2003","unstructured":"Mutaguchi K, Yasumoto H, Mita K, Matsubara A, Shiina H, Igawa M, Dahiya R, Usui T (2003) Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res 63: 7717\u20137723","journal-title":"Cancer Res"},{"key":"BF6605669_CR18","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cncr.23033","volume":"110","author":"H Nagano","year":"2007","unstructured":"Nagano H, Miyamoto A, Wada H, Ota H, Marubashi S, Takeda Y, Dono K, Umeshita K, Sakon M, Monden M (2007a) Interferon-\u03b1 and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 110: 2493\u20132501","journal-title":"Cancer"},{"key":"BF6605669_CR19","first-page":"172","volume":"54","author":"H Nagano","year":"2007","unstructured":"Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshit K, Nakamori S, Monden M (2007b) Hepatic resection followed by IFN-\u03b1 and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology 54: 172\u2013179","journal-title":"Hepatogastroenterology"},{"key":"BF6605669_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jhep.2006.07.032","volume":"46","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M (2007) Role of the Fas\/FasL pathway in combination therapy with interferon-\u03b1 and fluorouracil against hepatocellular carcinoma in vitro. J Hepatol 46: 77\u201388","journal-title":"J Hepatol"},{"key":"BF6605669_CR21","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/sj.bjc.6605064","volume":"100","author":"T Noda","year":"2009","unstructured":"Noda T, Nagano H, Takemasa I, Yoshioka S, Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, Umeshita K, Matsuura N, Matsubara K, Doki Y, Mori M, Monden M (2009) Activation of Wnt\/\u03b2-catenin signalling pathway induces chemoresistance to interferon-\u03b1\/5-fluorouracil combination therapy for hepatocellular carcinoma. Br J Cancer 100: 1647\u20131658","journal-title":"Br J Cancer"},{"key":"BF6605669_CR22","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/cncr.21832","volume":"106","author":"S Obi","year":"2006","unstructured":"Obi S, Yoshida H, Toune R, Unuma T, Kanda M, Sato S, Tateishi R, Teratani T, Shiina S, Omata M (2006) Combination therapy of intraarterial 5-fluorouracil and systemic interferon-\u03b1 for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106: 1990\u20131997","journal-title":"Cancer"},{"key":"BF6605669_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/A:1005911319432","volume":"47","author":"Y Oh","year":"1998","unstructured":"Oh Y (1998) IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 47: 283\u2013293","journal-title":"Breast Cancer Res Treat"},{"key":"BF6605669_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"BF6605669_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.bjc.6602742","volume":"93","author":"H Ota","year":"2005","unstructured":"Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Nakamura M, Damdinsuren B, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M (2005) Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-\u03b1 and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer 93: 557\u2013564","journal-title":"Br J Cancer"},{"key":"BF6605669_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1200\/JCO.2003.10.103","volume":"21","author":"YZ Patt","year":"2003","unstructured":"Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM (2003) Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 21: 421\u2013427","journal-title":"J Clin Oncol"},{"key":"BF6605669_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cncr.10246","volume":"94","author":"M Sakon","year":"2002","unstructured":"Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M (2002) Combined intraarterial 5-fluorouracil and subcutaneous interferon-\u03b1 therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94: 435\u2013442","journal-title":"Cancer"},{"key":"BF6605669_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1349-7006.2007.00502.x","volume":"98","author":"Y Sato","year":"2007","unstructured":"Sato Y, Chen Z, Miyazaki K (2007) Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1\/tumor-derived cell adhesion factor\/mac25. Cancer Sci 98: 1055\u20131063","journal-title":"Cancer Sci"},{"key":"BF6605669_CR29","first-page":"3513","volume":"27","author":"A Subramanian","year":"2007","unstructured":"Subramanian A, Sharma AK, Banerjee D, Jiang WG, Mokbel K (2007) Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer. Anticancer Res 27: 3513\u20133518","journal-title":"Anticancer Res"},{"key":"BF6605669_CR30","first-page":"637","volume":"43","author":"A Tanaka","year":"1996","unstructured":"Tanaka A, Morimoto T, Yamaoka Y (1996) Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology 43: 637\u2013643","journal-title":"Hepatogastroenterology"},{"key":"BF6605669_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000011833","volume":"55","author":"T Urabe","year":"1998","unstructured":"Urabe T, Kaneko S, Matsushita E, Unoura M, Kobayashi K (1998) Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-\u03b1-2b for patients with locally advanced hepatocellular carcinoma. Oncology 55: 39\u201347","journal-title":"Oncology"},{"key":"BF6605669_CR32","first-page":"801","volume":"18","author":"H Wada","year":"2007","unstructured":"Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M (2007) Combination therapy of interferon-\u03b1 and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Oncol Rep 18: 801\u2013809","journal-title":"Oncol Rep"},{"key":"BF6605669_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2407-9-361","volume":"9","author":"H Wada","year":"2009","unstructured":"Wada H, Nagano H, Yamamoto H, Noda T, Murakami M, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M (2009) Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells. BMC Cancer 9: 361","journal-title":"BMC Cancer"},{"key":"BF6605669_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","volume":"132","author":"N Wajapeyee","year":"2008","unstructured":"Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132: 363\u2013374","journal-title":"Cell"},{"key":"BF6605669_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0168-8278(99)80197-4","volume":"30","author":"K Yamakado","year":"1999","unstructured":"Yamakado K, Tanaka N, Nakatsuka A, Matsumura K, Takase K, Takeda K (1999) Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein. J Hepatol 30: 660\u2013668","journal-title":"J Hepatol"},{"key":"BF6605669_CR36","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1158\/1078-0432.CCR-04-0794","volume":"10","author":"T Yamamoto","year":"2004","unstructured":"Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M (2004) Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)\/TRAIL receptor pathway to antitumor effects of interferon-\u03b1\/5-fluorouracil against hepatocellular carcinoma. Clin Cancer Res 10: 7884\u20137895","journal-title":"Clin Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605669","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:45:04Z","timestamp":1684413904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,20]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BF6605669"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605669","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,20]]}}}